PESAE02 | The fidelity of a pharmacy-based PrEP delivery model in Kenya: an unannounced standardized patient actor assessment | Poster exhibition | Implementation science of scaling up prevention (including PrEP) |
PESAE03 | Community preparedness to embrace new biomedical HIV prevention technologies. CHEDRA's experience with the Dapivirine vaginal ring and Female Sex Workers (FSWs) amidst a volatile atmosphere in Masaka, Uganda | Poster exhibition | Implementation science of scaling up prevention (including PrEP) |
PESAE04 | Optimising provider-initiated indicator condition guided testing for HIV to identify undiagnosed individuals: preliminary results of a multifaceted, multicentre intervention study | Poster exhibition | Implementation science of scaling up HIV testing |
PESAE05 | Index testing approaches for early diagnosis of PLHIV and treatment initiation for HIV epidemic control | Poster exhibition | Implementation science of scaling up HIV testing |
PESAE07 | Long term effects of donor transition processes and their potential influence on the realization of the country's 90-90-90 targets. Experiences from a subnational level in Uganda | Poster exhibition | Implementation science of scaling up HIV treatment |
PESAE08 | High rates of interruptions in HIV treatment in people living with HIV on ART less than three months across the age continuum | Poster exhibition | Implementation science of scaling up HIV treatment |
PESAE09 | Asynchronous prescribing of ART and antihypertensives results in frequent clinic visits despite multi-month dispensing of ART in Malawi | Poster exhibition | Scaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health) |
PESAE10 | Using a robust approach to rapidly scale up integration of cervical cancer screening and treatment of pre-cancerous lesions in HIV clinics | Poster exhibition | Scaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health) |
PESAE11 | Community antiretroviral therapy dispensation in Cameroon associated with superior client outcomes: a national evaluation | Poster exhibition | Strategies to enhance U=U communication and implementation |
PESAE12 | Awareness of U=U among sexual and gender minorities in Brazil, Mexico and Peru: differences according to self-reported HIV status | Poster exhibition | Strategies to enhance U=U communication and implementation |